NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments

Glycoconjugate Journal

Volumn 27, Issue 3, 2010, Pages 349-358

  Rademacher, Christoph ^a   Landström, Jens ^b   Sindhuwinata, Nora ^a   Palcic, Monica M ^c   Widmalm, Göran ^b   Peters, Thomas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c CARLSBERG LABORATORY   (Denmark)

Author keywords

Glycosyltransferase; Inhibitor; Spin lock filter; STD NMR

Indexed keywords

GALACTOSYLTRANSFERASE;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD GROUP B; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IC 50; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

BINDING SITES; GALACTOSYLTRANSFERASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 77952099549     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9282-5     Document Type: Article

References (39)

1. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E. (eds.): Essentials of glycobiology. Cold Spring Harbor Laboratory, New York (2009)
2. JR Brown MM Fuster R Li N Varki CA Glass JD Esko 2006 A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination Clin. Cancer Res. 12 2894 2901 10.1158/1078-0432.CCR-05-2745 1:CAS:528:DC%2BD28Xltlamtbw%3D 16675586 (Pubitemid 43752132)
3. R Kannagi 2004 Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited Glycoconj. J. 20 353 364 10.1023/B:GLYC.0000033631.35357.41 1:CAS:528: DC%2BD2cXlt1Oktbs%3D 15229399 (Pubitemid 39024043)
4. R Kannagi M Izawa T Koike K Miyazaki N Kimura 2004 Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis Cancer Sci. 95 377 384 10.1111/j.1349-7006.2004.tb03219.x 1:CAS:528:DC%2BD2cXltlaitLs%3D 15132763 (Pubitemid 38832679)
5. B Mathew RR Schmidt 2007 Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings Carbohydr. Res. 342 558 566 10.1016/j.carres.2006.08.016 1:CAS:528:DC%2BD2sXhtlWisbc%3D 16989791 (Pubitemid 46161400)
6. MM Palcic LD Heerze OP Srivastava O Hindsgaul 1989 A bisubstrate analog inhibitor for alpha(1-2)-fucosyltransferase J. Biol. Chem. 264 17174 17181 1:CAS:528:DyaK3cXnt1OmsQ%3D%3D 2551897
7. Jung, K.H., Schmidt, R.R.: Glycosyltransferase inhibitors. In: Wong, C.-H. (ed.) Carbohydrate-based drug discovery, pp. 609-659. Wiley-VCH, Weinheim (2003)
8. SR Hamilton TU Gerngross 2007 Glycosylation engineering in yeast: the advent of fully humanized yeast Curr. Opin. Biotechnol. 18 387 392 10.1016/j.copbio.2007.09.001 1:CAS:528:DC%2BD2sXhtlGhu77F 17951046 (Pubitemid 350116586)
9. B Muller C Schaub RR Schmidt 1998 Efficient sialyltransferase inhibitors based on transition-state analogues of the sialyl donor Angew. Chem. Int. Edit. 37 2893 2897 10.1002/(SICI)1521-3773(19981102)37:20<2893::AID-ANIE2893>3. 0.CO;2-W 1:CAS:528:DyaK1cXnsVGksrs%3D (Pubitemid 29008587)
10. C Schaub B Muller RR Schmidt 1998 New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay Glycoconj. J. 15 345 354 10.1023/A:1006917717161 1:CAS:528:DyaK1cXivV2htrs%3D 9613821 (Pubitemid 28193042)
11. D Skropeta R Schworer T Haag RR Schmidt 2004 Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues Glycoconj. J. 21 205 219 10.1023/B:GLYC.0000045093.96413.62 1:CAS:528:DC%2BD2cXosVSkurs%3D 15486453 (Pubitemid 39388739)
12. M Izumi H Yuasa H Hashimoto 2009 Bisubstrate analogues as glycosyltransferase inhibitors Curr. Top Med. Chem. 9 87 105 10.2174/156802609787354351 1:CAS:528:DC%2BD1MXkvVSnsLk%3D 19199998
13. M Izumi S Kaneko H Yuasa H Hashimoto 2006 Synthesis of bisubstrate analogues targeting alpha-1, 3-fucosyltransferase and their activities Org. Biomol. Chem. 4 681 690 10.1039/b513897c 1:CAS:528:DC%2BD28Xht1Wrtbo%3D 16467942 (Pubitemid 43237726)
14. MH Yazer ML Olsson MM Palcic 2006 The cis-AB blood group phenotype: fundamental lessons in glycobiology Transfus. Med. Rev. 20 207 217 10.1016/j.tmrv.2006.03.002 16787828 (Pubitemid 43922452)
15. JA Alfaro RB Zheng M Persson JA Letts R Polakowski Y Bai SN Borisova NO Seto TL Lowary MM Palcic SV Evans 2008 ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes J. Biol. Chem. 283 10097 10108 10.1074/jbc.M708669200 1:CAS:528: DC%2BD1cXkt1alu70%3D 18192272
16. SI Patenaude NO Seto SN Borisova A Szpacenko SL Marcus MM Palcic SV Evans 2002 The structural basis for specificity in human ABO(H) blood group biosynthesis Nat. Struct. Biol. 9 685 690 10.1038/nsb832 1:CAS:528: DC%2BD38Xms1ajtbo%3D 12198488 (Pubitemid 34977302)
17. M Mayer B Meyer 1999 Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem. Int. Ed. 38 1784 1788 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q 1:CAS:528:DyaK1MXktVCntb0%3D (Pubitemid 29290947)
18. T Scherf J Anglister 1993 A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens Biophys. J. 64 754 761 10.1016/S0006-3495(93)81436-X 1:CAS:528:DyaK3sXisFSqsrw%3D 8386014 (Pubitemid 23130342)
19. W Jahnke S Rudisser M Zurini 2001 Spin label enhanced NMR screening J. Am. Chem. Soc. 123 3149 3150 10.1021/ja005836g 1:CAS:528:DC%2BD3MXhs1agtrw%3D 11457032 (Pubitemid 32879588)
20. B Meyer T Peters 2003 NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors Angew. Chem. Int. Ed. Engl. 42 864 890 10.1002/anie.200390233 1:CAS:528:DC%2BD3sXitFWltL4%3D 12596167 (Pubitemid 36314024)
21. C Ludwig UL Guenther 2009 Ligand based NMR methods for drug discovery Front. Biosci. 14 4565 4574 10.2741/3549 1:CAS:528:DC%2BD1MXltlKhu7g%3D 19273371
22. T Diercks M Coles H Kessler 2001 Applications of NMR in drug discovery Curr. Opin. Chem. Biol. 5 285 291 10.1016/S1367-5931(00)00204-0 1:CAS:528:DC%2BD3MXktlShtLY%3D 11479120 (Pubitemid 32718525)
23. M Coles M Heller H Kessler 2003 NMR-based screening technologies Drug. Discov. Today 8 803 810 10.1016/S1359-6446(03)02796-X 1:CAS:528: DC%2BD3sXms1yitL4%3D 12946643 (Pubitemid 37011306)
24. M Pellecchia I Bertini D Cowburn C Dalvit E Giralt W Jahnke TL James SW Homans H Kessler C Luchinat B Meyer H Oschkinat J Peng H Schwalbe G Siegal 2008 Perspectives on NMR in drug discovery: a technique comes of age Nat. Rev. Drug Discov. 7 738 745 10.1038/nrd2606 1:CAS:528:DC%2BD1cXhtVGgtL%2FK 19172689
25. DF Wyss MA McCoy MM Senior 2002 NMR-based approaches for lead discovery Curr. Opin. Drug Discov. Devel. 5 630 647 1:CAS:528:DC%2BD3sXns1eisw%3D%3D 12197321
26. SL Marcus R Polakowski NO Seto E Leinala S Borisova A Blancher F Roubinet SV Evans MM Palcic 2003 A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase J. Biol. Chem. 278 12403 12405 10.1074/jbc.M212002200 1:CAS:528:DC%2BD3sXisVOntLo%3D 12529355 (Pubitemid 36800226)
27. TL Hwang AJ Shaka 1995 Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson. A 112 275 279 10.1006/jmra.1995.1047 1:CAS:528:DyaK2MXjs1Wmsb0%3D
28. Sindhuwinata, N., Miunoz, E., Munoz, F.J., Palcic, M.M., Peters, H., Peters, T.: Binding of an acceptor substrate analog enhances the enzymatic activity of human blood group B galactosyltransferase. Glycobiology. in press.
29. Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J.: AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. (2009)
30. A Blume J Angulo T Biet H Peters AJ Benie M Palcic T Peters 2006 Fragment-based screening of the donor substrate specificity of human blood group B galactosyltransferase using saturation transfer difference NMR J. Biol. Chem. 281 32728 32740 10.1074/jbc.M600424200 1:CAS:528:DC%2BD28XhtFSrtr3P 16923820 (Pubitemid 46036829)
31. GK Shoemaker N Soya MM Palcic JS Klassen 2008 Temperature-dependent cooperativity in donor-acceptor substrate binding to the human blood group glycosyltransferases Glycobiology 18 587 592 10.1093/glycob/cwn043 1:CAS:528:DC%2BD1cXoslGls7k%3D 18509110
32. BJ Stockman C Dalvit 2002 NMR screening techniques in drug discovery and drug design Prog. Nucl. Magn. Reson. Spectrosc. 41 187 231 10.1016/S0079- 6565(02)00049-3 1:CAS:528:DC%2BD38XovFCjsLs%3D (Pubitemid 35432569)
33. C Dalvit M Flocco S Knapp M Mostardini R Perego BJ Stockman M Veronesi M Varasi 2002 High-throughput NMR-based screening with competition binding experiments J. Am. Chem. Soc. 124 7702 7709 10.1021/ja020174b 1:CAS:528:DC%2BD38Xkt1Clsb4%3D 12083923 (Pubitemid 34733782)
34. F Manzenrieder AO Frank H Kessler 2008 Phosphorus NMR spectroscopy as a versatile tool for compound library screening Angew. Chem. Int. Ed. Engl. 47 2608 2611 10.1002/anie.200705256 1:CAS:528:DC%2BD1cXkvFaqs7g%3D 18311739
35. J Klages M Coles H Kessler 2007 NMR-based screening: a powerful tool in fragment-based drug discovery Analyst 132 693 705 10.1039/b709658p 1:CAS:528:DC%2BD2sXmvVOms7c%3D 17657909
36. M Leone HH Freeze CS Chan M Pellecchia 2006 The Nuclear overhauser effect in the lead identification process Curr. Drug. Discov. Technol. 3 91 100 10.2174/157016306778108884 1:CAS:528:DC%2BD28XhtVSjsrzO 16925517 (Pubitemid 44285195)
37. DS Sem M Pellecchia 2001 NMR in the acceleration of drug discovery Curr. Opin. Drug Discov. Devel. 4 479 492 1:CAS:528:DC%2BD3MXlsVKkur4%3D 11727313 (Pubitemid 32678537)
38. A Schuffenhauer S Ruedisser AL Marzinzik W Jahnke M Blommers P Selzer E Jacoby 2005 Library design for fragment based screening Curr. Top Med. Chem. 5 751 762 10.2174/1568026054637700 1:CAS:528:DC%2BD2MXpsFGht78%3D 16101415 (Pubitemid 41179715)
39. S Rudisser W Jahnke 2002 NMR and in silico screening Comb. Chem. High Throughput Screen 5 591 603 1:CAS:528:DC%2BD38XovF2qtLs%3D 12470256 (Pubitemid 35387856)